Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Tewfik Miloud, Manuela Battaglia et al.|The Lancet|2020Cited by 445
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Christopher D. Buckley, Matthias Friedrich et al.|Nature Immunology|2024Cited by 83
Systemic silencing of Phd2 causes reversible immune regulatory dysfunctionAtsushi Yamamoto, Christopher W. Pugh, Joanna Hester et al.|Journal of Clinical Investigation|2019Cited by 35
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian CancersZhiyuan Hu, Ahmed Ahmed, Paula Cunnea et al.|Clinical Cancer Research|2021Cited by 23